share_log
Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

Precipio Inc股价重挫10.23% 市值跌207.75万美元

自選股智能寫手 ·  06/13/2022 23:44

北京时间2022年06月13日23时12分,Precipio Inc(PRPO.us)股票出现波动,股价大幅下跌10.23%。截至发稿,该股报1.05美元/股,成交量9.283万股,换手率0.41%,振幅6.84%。

最近的财报数据显示,该股实现营业收入2.45百万美元,净利润-4.59百万美元,每股收益-0.20美元,毛利321000.00美元,市盈率-2.06倍。

机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。

Precipio Inc股票所在的生命科学行业中,整体跌幅为3.28%。其相关个股中,Seqll Inc、Lumiradx Ltd、23Andme Holding Co涨幅较大,Invitae Corp、Dermtech Inc、Htg Molecular Diagnostics Inc较为活跃,换手率分别为1.62%、1.55%、1.34%,振幅较大的相关个股有Check-Cap Ltd C/Wts 03/05/2023(To Pur Com)Series C、Star Equity Holdings Inc、Biodesix Inc,振幅分别为60.00%、19.68%、19.37%。

Precipio Inc公司简介:Precipio Inc是一家专注于癌症诊断的医疗保健解决方案公司。它侧重于解决癌症误诊问题,通过开发解决方案,以诊断产品、试剂和服务的形式减轻这一问题的影响。该公司在康涅狄格州的纽黑文和内布拉斯加州的奥马哈运营临床实验室改进实验室,为全国许多州的办公室肿瘤学家提供基本的血癌诊断。它以HemeScreen和IV-Cell产品的形式为肿瘤诊断实验室市场提供新技术。

(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.